• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝内脂肪酸氧化升高、血浆成纤维细胞生长因子 21 水平升高和空腹胆汁酸水平升高。
Eur J Gastroenterol Hepatol. 2011 May;23(5):382-8. doi: 10.1097/MEG.0b013e328345c8c7.
2
Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.人类非酒精性脂肪性肝炎中甘氨酸和尿素动力学:脂肪乳剂输注的影响。
Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G567-75. doi: 10.1152/ajpgi.00042.2009. Epub 2009 Jul 1.
3
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
4
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.血浆成纤维细胞生长因子 21 与肥胖和 2 型糖尿病患者非酒精性脂肪性肝炎严重程度相关。
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3327-3336. doi: 10.1210/jc.2018-02414.
5
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.肥胖症和非酒精性脂肪性肝病中成纤维细胞生长因子21水平升高。
Gastroenterology. 2010 Aug;139(2):456-63. doi: 10.1053/j.gastro.2010.04.054. Epub 2010 May 5.
6
Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.脂联素受体(AdipoR1/R2)和肝胰岛素受体底物同工型(IRS-1/-2)对非酒精性脂肪性肝炎动物模型中脂肪酸合成和氧化的调节。
Metabolism. 2011 Jun;60(6):805-14. doi: 10.1016/j.metabol.2010.07.032. Epub 2010 Sep 16.
7
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.非酒精性脂肪性肝炎:胰岛素抵抗与线粒体异常的关联
Gastroenterology. 2001 Apr;120(5):1183-92. doi: 10.1053/gast.2001.23256.
8
A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.一种利用全肠内营养过量喂食高多不饱和脂肪饮食的大鼠非酒精性脂肪性肝炎新模型。
Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G27-38. doi: 10.1152/ajpgi.00296.2007. Epub 2007 Oct 18.
9
The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.FGF19 对肝脏的反应在非酒精性脂肪性肝病和胰岛素抵抗患者中受损。
Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G440-5. doi: 10.1152/ajpgi.00322.2009. Epub 2010 Jan 21.
10
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎患者胆汁酸代谢组的改变
Dig Dis Sci. 2015 Nov;60(11):3318-28. doi: 10.1007/s10620-015-3776-8. Epub 2015 Jul 3.

引用本文的文献

1
Skeletal Muscle and Cardiovascular Health.骨骼肌与心血管健康。
Adv Exp Med Biol. 2025;1478:631-659. doi: 10.1007/978-3-031-88361-3_26.
2
Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies.代谢功能障碍相关脂肪性肝病进展中的酮类代谢产物:优化酮治疗策略
Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E290-E301. doi: 10.1152/ajpendo.00178.2025. Epub 2025 Jul 7.
3
Evaluation of FXR Activity in Pollutants Identified in Sewage Sludge and Subsequent and Characterization of Metabolic Effects of Triphenyl Phosphate.污水污泥中鉴定出的污染物中法尼醇X受体(FXR)活性评估及磷酸三苯酯代谢效应的表征
Environ Health Perspect. 2025 Apr;133(3-4):47005. doi: 10.1289/EHP15435. Epub 2025 Apr 14.
4
Microbial transformations of bile acids and their receptors in the regulation of metabolic dysfunction-associated steatotic liver disease.胆汁酸的微生物转化及其受体在代谢功能障碍相关脂肪性肝病调节中的作用
Liver Res. 2023 Sep 11;7(3):165-176. doi: 10.1016/j.livres.2023.09.002. eCollection 2023 Sep.
5
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.胆汁酸激活受体:整合非酒精性脂肪性肝病中的免疫与代谢调节
Liver Res. 2021 Sep 2;5(3):119-141. doi: 10.1016/j.livres.2021.08.003. eCollection 2021 Sep.
6
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD.肠道微生物群处于肝脏氧化应激与代谢相关脂肪性肝病的交叉点
Antioxidants (Basel). 2025 Jan 6;14(1):56. doi: 10.3390/antiox14010056.
7
Regulation of Mitochondrial and Peroxisomal Metabolism in Female Obesity and Type 2 Diabetes.女性肥胖和 2 型糖尿病中线粒体和过氧化物酶体代谢的调节。
Int J Mol Sci. 2024 Oct 19;25(20):11237. doi: 10.3390/ijms252011237.
8
Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice.口服补充肠道微生物代谢产物吲哚-3-乙酸可缓解小鼠饮食诱导的脂肪变性和炎症。
Elife. 2024 Feb 27;12:RP87458. doi: 10.7554/eLife.87458.
9
Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD.肥胖症和非酒精性脂肪性肝病患者血清β-羟丁酸与肝内脂肪酸氧化的关系。
Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E493-E502. doi: 10.1152/ajpendo.00336.2023. Epub 2024 Feb 21.
10
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD).代谢相关脂肪性肝病(MASLD)中的脂质代谢
Metabolites. 2023 Dec 23;14(1):12. doi: 10.3390/metabo14010012.

本文引用的文献

1
Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals.通过正电子发射断层扫描测量的肝脏脂肪酸代谢在肥胖个体中增加。
Gastroenterology. 2010 Sep;139(3):846-56, 856.e1-6. doi: 10.1053/j.gastro.2010.05.039. Epub 2010 May 25.
2
Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.肥胖是成纤维细胞生长因子 21(FGF21)抵抗状态。
Diabetes. 2010 Nov;59(11):2781-9. doi: 10.2337/db10-0193. Epub 2010 Aug 3.
3
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者血清 FGF21 水平升高。
Eur J Clin Invest. 2010 Oct;40(10):887-92. doi: 10.1111/j.1365-2362.2010.02338.x. Epub 2010 Aug 19.
4
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.肥胖症和非酒精性脂肪性肝病中成纤维细胞生长因子21水平升高。
Gastroenterology. 2010 Aug;139(2):456-63. doi: 10.1053/j.gastro.2010.04.054. Epub 2010 May 5.
5
Plasma metabolomic profile in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的血浆代谢组学特征。
Metabolism. 2011 Mar;60(3):404-13. doi: 10.1016/j.metabol.2010.03.006. Epub 2010 Apr 27.
6
Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry.采用液相色谱-电喷雾串联质谱法对生物样本中的神经酰胺种类进行定量分析。
Anal Biochem. 2010 Jun 1;401(1):154-61. doi: 10.1016/j.ab.2010.02.023. Epub 2010 Feb 21.
7
High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei.高脂肪饮食诱导大鼠肝细胞核中神经酰胺和神经鞘磷脂的形成。
Mol Cell Biochem. 2010 Jul;340(1-2):125-31. doi: 10.1007/s11010-010-0409-6. Epub 2010 Feb 20.
8
Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study.实时超声诊断肝脂肪变的有效性:一项前瞻性研究。
J Hepatol. 2009 Dec;51(6):1061-7. doi: 10.1016/j.jhep.2009.09.001. Epub 2009 Sep 20.
9
Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.成纤维细胞生长因子21缺陷型小鼠表现出对酮症适应能力受损。
Endocrinology. 2009 Nov;150(11):4931-40. doi: 10.1210/en.2009-0532. Epub 2009 Oct 9.
10
Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease.系统评价:细胞角蛋白 18 的半胱天冬酶剪切片段——一种慢性肝病生物标志物的前景与挑战。
Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1103-9. doi: 10.1111/j.1365-2036.2009.04148.x. Epub 2009 Sep 21.

非酒精性脂肪性肝炎患者肝内脂肪酸氧化升高、血浆成纤维细胞生长因子 21 水平升高和空腹胆汁酸水平升高。

Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.

机构信息

Department of Gastroenterology, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Eur J Gastroenterol Hepatol. 2011 May;23(5):382-8. doi: 10.1097/MEG.0b013e328345c8c7.

DOI:10.1097/MEG.0b013e328345c8c7
PMID:21448070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3493151/
Abstract

BACKGROUND

Data from studies in patients with nonalcoholic steatohepatitis (NASH) suggest an increased hepatic fatty acid oxidation. We have previously shown higher fasting plasma bile acid concentrations in patients with NASH. In-vivo and in-vitro studies suggest that bile acids by binding to peroxisome proliferator-activated receptor α activate fibroblast growth factor 21 (FGF21) and increase hepatic fatty acid oxidation.

METHODS

Plasma bile acid levels were quantified in healthy controls (n=38) and patients with biopsy-proven NASH (n=36). Plasma concentration of fatty acids, β-hydroxybutyrate, insulin, glucose, leptin, alanine aminotransferase, FGF21, and 8-hydroxydeoxyguanosine, a measure of oxidative stress, were measured in 16 healthy controls and 10 patients with NASH in the fasted state and in response to 3 h of infusion of intralipid. In a subgroup of these patients (n=6 each), plasma ceramide subspecies were quantified.

RESULTS

Fasting plasma bile acids, FGF21, and leptin concentrations were significantly higher in patients with NASH. In response to intralipid infusion there was an increase in plasma β-hydroxybutyrate and free fatty acid levels in both controls and NASH; however, the ratio of β-hydroxybutyrate/free fatty acid was higher in NASH (P=0.02). Plasma FGF21 concentration increased in response to intralipid in patients with NASH only (P<0.01). Plasma leptin, insulin, glucose, and alanine transferase concentrations did not change in either group after infusion of intralipid. Increase in total ceramides in response to intralipid was greater in NASH.

CONCLUSION

Elevated bile acids and FGF21 may be responsible for the higher hepatic fatty acid oxidation in NASH.

摘要

背景

来自非酒精性脂肪性肝炎(NASH)患者研究的数据表明肝脂肪酸氧化增加。我们之前已经表明 NASH 患者空腹血浆胆汁酸浓度较高。体内和体外研究表明,胆汁酸通过与过氧化物酶体增殖物激活受体-α结合激活成纤维细胞生长因子 21(FGF21)并增加肝脂肪酸氧化。

方法

在健康对照组(n=38)和经活检证实的 NASH 患者(n=36)中定量测定血浆胆汁酸水平。在空腹状态下和在输注中 3 小时内,在 16 名健康对照者和 10 名 NASH 患者中测量了血浆脂肪酸、β-羟丁酸、胰岛素、葡萄糖、瘦素、丙氨酸氨基转移酶、FGF21 和 8-羟基脱氧鸟苷的浓度,8-羟基脱氧鸟苷是氧化应激的衡量标准。在这些患者的亚组中(n=6 人),定量测定了血浆神经酰胺亚种。

结果

NASH 患者的空腹血浆胆汁酸、FGF21 和瘦素浓度明显更高。在输注中,对照组和 NASH 患者的血浆β-羟丁酸和游离脂肪酸水平均升高;然而,NASH 中的β-羟丁酸/游离脂肪酸比值更高(P=0.02)。仅在 NASH 患者中,FGF21 对输注中脂肪乳的反应增加(P<0.01)。在输注脂肪乳后,两组的血浆瘦素、胰岛素、葡萄糖和丙氨酸转氨酶浓度均未发生变化。对脂肪乳的总神经酰胺反应增加在 NASH 中更大。

结论

升高的胆汁酸和 FGF21 可能是 NASH 中肝脂肪酸氧化增加的原因。